To earn CME related to this news article, click here. April 27, 2009 (Chicago, Illinois) — The American Urological Association (AUA) issued new guidelines today during its 104th annual meeting. The ...

PSA levels measured at age 60 predict a man’s lifetime risk of metastasis and death from prostate cancer (PCa), according to a study published online in the British Medical Journal. Hans Lilja, MD, ...

Overdiagnosis from prostate-specific antigen (PSA) screening rises sharply with age, reaching about one third of prostate cancers detected at age 70. Approximately 11.7% of screen-detected prostate ...

Speakers discussed the disparities in prostate-specific antigen (PSA) screening rates among different racial groups and explored the potential of free PSA percentage as a predictive marker for future ...

This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...